Patents Assigned to PHARMOSA BIOPHARM INC.
  • Liposome compositions comprising weak acid drugs and uses thereof
    Patent number: 11964050
    Abstract: The present invention relates to a pharmaceutical composition comprising a weak acid drug, with the use of a bicarbonate salt to achieve a high incorporation of the drug into the liposome and a better therapeutic efficacy. Also disclosed is a method for treating a respiratory disease using the pharmaceutical composition disclosed herein.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: April 23, 2024
    Assignee: PHARMOSA BIOPHARM INC.
    Inventors: Pei Kan, Yi Fong Lin, Ko Chieh Chen
  • Pharmaceutical composition for controlled release of treprostinil
    Patent number: 11833125
    Abstract: Provided herein are pharmaceutical compositions containing (a) at least one liposome includes at least one vesicle-forming phospholipid; and (b) treprostinil encapsulated within the liposome. The ratio of treprostinil to phospholipid is equal to or higher than 0.035 and provides a controlled release of treprostinil. Also provided is the use of the pharmaceutical compositions to treat respiratory diseases.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: December 5, 2023
    Assignee: PHARMOSA BIOPHARM INC.
    Inventors: Pei Kan, Yi Fong Lin, Ko Chieh Chen
  • Pharmaceutical composition for controlled release of treprostinil
    Patent number: 11229616
    Abstract: Provided herein are pharmaceutical compositions containing (a) at least one liposome includes at least one vesicle-forming phospholipid; and (b) treprostinil encapsulated within the liposome. The ratio of treprostinil to phospholipid is equal to or higher than 0.035 and provides a controlled release of treprostinil. Also provided is the use of the pharmaceutical compositions to treat respiratory diseases.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: January 25, 2022
    Assignee: PHARMOSA BIOPHARM INC.
    Inventors: Pei Kan, Yi Fong Lin, Ko Chieh Chen